Early-stage melanoma: Clinical signs clinicians check

Assessment of a concerning skin spot usually combines visual inspection, patient history, and careful attention to change over time. Clinicians do not rely on a single feature alone. Instead, they look at overall pattern, whether the lesion stands out from surrounding spots, and whether it has changed in appearance, size, or symptoms. A biopsy is needed to confirm a diagnosis. This article is for informational purposes only and should not be considered medical advice. Please consult a qualified healthcare professional for personalized guidance and treatment.

How suspicious lesions are assessed

A clinician typically starts with the patient’s history: when the spot appeared, whether it has grown, and if it itches, bleeds, crusts, or becomes tender. Visual examination then focuses on symmetry, edge quality, color pattern, and surface structure. Many clinicians also use dermoscopy, a handheld tool that makes pigment patterns and blood vessel structures easier to see. This can help distinguish harmless lesions from those that deserve biopsy, although no visual method replaces tissue testing.

The ABCDE pattern in skin lesions

The ABCDE guide remains one of the most familiar ways to screen pigmented lesions. A stands for asymmetry, meaning one half does not match the other. B refers to border irregularity, such as edges that look ragged, blurred, or notched. C is color variation, especially when tan, brown, black, red, white, or blue appear in one lesion. D stands for diameter, often noted when a lesion is larger than about 6 millimeters, though smaller lesions can still be important. E means evolving, which many clinicians consider the most useful warning sign.

Changes in new or existing spots

A new spot appearing in adulthood often deserves attention, especially if it looks different from a person’s usual moles. Clinicians also watch for enlarging, darkening, flattening, or raised lesions, as well as changes in texture. A spot that begins to itch, bleed easily, form a crust, or heal poorly may also raise concern. Another practical clue is the ugly duckling sign: a lesion that clearly looks unlike a patient’s other moles. Even if the ABCDE features are incomplete, noticeable change can be a reason to investigate.

Amelanotic and non-mole presentations

Not every suspicious lesion is dark brown or black. Some appear pink, red, skin-colored, or nearly colorless. These amelanotic lesions can be harder to recognize because they lack obvious pigment and may resemble eczema, a pimple, a scar, or a small sore. Clinicians may become concerned when such a lesion persists, enlarges, bleeds, or develops an unusual vascular pattern under dermoscopy. Melanoma can also arise in lesions that do not resemble a classic mole, which is why persistent atypical spots should not be dismissed simply because they are pale.

Common body sites and higher-risk areas

These lesions can appear almost anywhere on the body, including places with little sun exposure. Common sites include the back, chest, legs, arms, and scalp. In women, the legs are often noted as a frequent location, while in men the trunk and back are common areas. Clinicians also examine the palms, soles, nail units, and mucosal surfaces when symptoms or appearance suggest concern. Areas that are difficult for people to inspect themselves, such as the back or scalp, can delay recognition, making full-skin examination important in selected patients.

Why context matters in clinical evaluation

Visual signs are interpreted alongside personal risk factors. Clinicians pay close attention to a history of intense ultraviolet exposure, blistering sunburns, many moles, atypical moles, fair skin, family history, or a previous history of skin cancer. Immune suppression can also increase concern. A lesion that looks only mildly unusual in isolation may become more important when the patient has several risk factors or reports definite recent change. For this reason, clinical judgment depends on both what the spot looks like and who the patient is.

No single checklist identifies every dangerous lesion, and some harmless spots can look worrisome at first glance. The most important clinical themes are asymmetry, irregular border, varied color, change over time, unusual symptoms, and lesions that do not fit a person’s typical skin pattern. Less obvious pink or colorless lesions also matter. When uncertainty remains after examination, biopsy provides the definitive answer and helps guide appropriate next steps.